证券代码：300214 证券简称：日科化学 公告编号：2025-063 山东日科化学股份有限公司 二、其他说明 公司回购股份的数量、比例、回购价格、使用金额以及回购方式、委托时间 段等符合《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9号——回购股份》以及公司回购方案的相关规定，具体为： 1、公司未在下列期间回购公司股票： 关于回购公司股份进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东日科化学股份有限公司（以下简称"公司"）于 2024 年 12 月 31 日召 开第五届董事会第二十七次会议，审议通过《关于回购股份方案的议案》。公司 以集中竞价交易方式从二级市场回购 A 股股份，回购的股份用于实施员工持股 计划或股权激励计划，回购股份的资金总额不低于人民币 3,000 万元（含）且不 超过人民币 5,000 万元（含），回购价格不超过人民币 7 元/股（含），具体回购 股份的数量及占公司总股本的比例以实际回购的股份数量和占公司总股本的比 例为准。本次回购股份实施期限为自董事会审议通过本次回购股份方案之日起 12 个月内。具体 ...

证券代码：300214 证券简称：日科化学 公告编号：2025-061 1、审议通过了《关于全资间接控股子公司对外出售资产的议案》 山东日科化学股份有限公司 第六届董事会第六次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、本次董事会会议的通知在2025年6月27日以专人方式发出。 2、本次董事会会议于2025年6月30日在公司会议室以现场方式召开。 3、本次董事会会议应出席董事5人，实际出席会议董事5人。 4、本次董事会会议由董事长田志龙先生主持，监事会主席韩成功先生列席 会议。 5、本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性文 件和公司章程的规定。 二、董事会会议审议情况 为满足公司整体战略规划与经营效益提升的需求，盘活公司闲置资产，提高 资产运营效率，本次会议同意公司全资间接控股子公司山东日科塑胶有限公司向 山东氢能动力科技有限公司出售国有土地使用权证号为"潍国用（2009）第11003 号"的48,117平方米工业用地，以及仓库、车间等地上建筑物和部分二手、非全 新设备，交易总金额为4,500 ...

证券代码：300214 证券简称：日科化学 公告编号：2025-062 山东日科化学股份有限公司 关于全资间接控股子公司对外出售资产的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 山东日科化学股份有限公司全资间接控股子公司山东日科塑胶有限 公司拟向山东氢能动力科技有限公司出售国有土地使用权证号为"潍国用 （2009）第 11003 号"的 48,117 平方米工业用地，以及仓库、车间等地上建筑 物和部分二手、非全新设备，本次交易总金额为 4,500 万元。 本次交易已经公司第六届董事会第六次会议审议通过，无需提交股 东会审议。 风险提示：本次交易尚需受让方投资项目获得环保部门批复，合同方能 生效；合同生效后，尚需交易双方根据不动产交易过户的相关规定，完成款项支 付及不动产交接、办理产权过户登记等相关手续，并按照国家法律法规规定缴纳 各项税费后方能正式完成。因此，本次交易存在不确定性。本次出售资产所得款 项在扣除成本及相关费用支出后，将在 2025 年度按照企业会计准则的规定进行 会计处理，预计会对公司 2025 年度经营业绩带来积极影响 ...

证券代码：300214 证券简称：日科化学 公告编号：2025-059 山东日科化学股份有限公司 关于间接控股子公司对外投资成立合资公司的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、对外投资概况 （一）基本情况 根据山东日科化学股份有限公司（以下简称"公司"）战略发展需要，公司全 资子公司哈金贝斯（上海）智能科技有限公司（以下简称"哈金贝斯"）之控股子 公司克拉玛依碳和网络科技有限公司（以下简称"碳和科技"）拟与克拉玛依融汇 投资集团有限公司（以下简称"融汇公司"）合资成立克拉玛依融和智算科技有限 公司（暂定名，以克拉玛依区工商监督管理局核准名称为准，以下简称"融和智 算"）。 合资公司的注册资本为人民币 4,000 万元，其中碳和科技以货币资金出资人 民币 1,960 万元，占注册资本的 49%；融汇公司以货币资金出资人民币 2,040 万 元，占注册资本的 51%。 上述交易统称为"本次投资"。 （二）董事会审议情况 本次投资已于 2025 年 6 月 18 日经公司第六届董事会第五次会议审议通过， 根据《深圳证券交易所创业板股票上市规则》及 ...

Core Viewpoint - The legal opinion letter from Shandong Deheng (Jinan) Law Firm confirms that Shandong Rike Chemical Co., Ltd.'s 2025 Restricted Stock Incentive Plan has obtained the necessary approvals and complies with relevant laws and regulations [2][10]. Group 1: Approval and Authorization - The company has completed the necessary procedures for the initial grant of the incentive plan, including passing relevant resolutions and submitting them for board review [3][4]. - The board has determined that the conditions for the initial grant of the incentive plan have been met, and the list of recipients has been publicly disclosed [5][6]. Group 2: Grant Details - The initial grant date for the incentive plan is set for July 4, 2025, following the approval of the second temporary shareholders' meeting [6][9]. - The company plans to grant 18.3 million shares of second-class restricted stock at a price of 5.26 yuan per share to 15 eligible recipients [9][10]. Group 3: Grant Conditions - The grant of restricted stock is contingent upon meeting specific conditions outlined in the incentive plan, including compliance with legal and regulatory requirements [7][8]. - The company and the recipients have confirmed that they do not fall under any disqualifying conditions for receiving the restricted stock [8][10].

Core Viewpoint - The Supervisory Board of Shandong Rike Chemical Co., Ltd. has verified the list of initial grant recipients for the 2025 restricted stock incentive plan, confirming that the recipients meet the necessary qualifications and conditions as per relevant laws and regulations [1][2]. Summary by Relevant Sections Incentive Plan Overview - The company is implementing a restricted stock incentive plan for 2025, with the initial grant price set at 5.26 yuan per share for 18.3 million shares [2]. Eligibility Criteria - The eligible recipients of the incentive plan must not have been identified as inappropriate candidates by the stock exchange or the China Securities Regulatory Commission (CSRC) within the last 12 months, nor can they have faced administrative penalties or market entry bans due to significant violations [1]. - Additional disqualifications include any legal restrictions under the Company Law or other relevant regulations that prevent participation in stock incentive plans [1]. Approval Process - The Supervisory Board has agreed to the list of initial grant recipients and will present this plan for approval at the company's second extraordinary general meeting in 2025 [2].

Group 1 - The company held a supervisory board meeting to discuss the incentive plan for granting restricted stock to eligible participants [1][2] - The supervisory board approved the plan to grant 18.3 million shares of restricted stock to 15 eligible participants at a price of 5.26 yuan per share, pending approval from the shareholders' meeting [1][2] - The initial grant date for the restricted stock will be July 4, 2025, following the approval of the proposal at the second extraordinary shareholders' meeting [1]

Meeting Information - The company will hold its second extraordinary general meeting of shareholders on July 4, 2025, at 14:30 [1] - The meeting will include both on-site and online voting options for shareholders [1][4] Voting Procedures - Shareholders can vote through the Shenzhen Stock Exchange trading system or the internet voting system during specified times on July 4, 2025 [1][4] - Only one voting method can be selected by each shareholder, and duplicate votes will be disregarded, with the first vote counted as valid [1][4] Agenda Items - The meeting will discuss two main proposals: 1. Authorization for the board to handle matters related to the 2025 restricted stock incentive plan [2][3] 2. Application for comprehensive credit from financing leasing institutions and guarantees from wholly-owned subsidiaries [2][3] Shareholder Participation - All shareholders registered by June 27, 2025, are entitled to attend and vote at the meeting [2] - Shareholders unable to attend can appoint a proxy to vote on their behalf [2][4] Special Voting Considerations - Certain related shareholders must abstain from voting on specific proposals to protect the interests of minority investors, who will have their votes counted separately [3]

Core Viewpoint - The company plans to apply for a total credit limit of up to RMB 2.5 billion from banks and an additional credit limit of up to RMB 500 million from financing leasing institutions to ensure sufficient liquidity for its operations [1][2]. Group 1 - The company held its sixth board meeting on April 17, 2025, and approved the proposal to apply for a comprehensive credit limit from banks at the annual shareholders' meeting on May 15, 2025 [1]. - The total credit amount from banks will not exceed RMB 2.5 billion, with the specific financing amount determined by the actual operational needs of the company and its subsidiaries [1]. - The validity period for the approved credit limit is from the date of approval at the 2024 annual shareholders' meeting until the 2025 annual shareholders' meeting [1]. Group 2 - The company intends to apply for a comprehensive credit limit of up to RMB 500 million from financing leasing institutions, with a term of one year [2]. - The specific financing products include but are not limited to short-term working capital loans, bank acceptance bills, domestic letters of credit, and trade financing [2]. - The company's wholly-owned subsidiary, Shandong Rike Rubber and Plastic Technology Co., Ltd., will provide joint liability guarantee for the bank and financing leasing credit business, with a limit not exceeding RMB 1 billion [2].

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、对外投资概况 （一）基本情况 根据山东日科化学股份有限公司（以下简称"公司"）战略发展需要，公司全 资子公司哈金贝斯（上海）智能科技有限公司（以下简称"哈金贝斯"）之控股子 公司克拉玛依碳和网络科技有限公司（以下简称"碳和科技"）拟与克拉玛依融汇 投资集团有限公司（以下简称"融汇公司"）合资成立克拉玛依融和智算科技有限 公司（暂定名，以克拉玛依区工商监督管理局核准名称为准，以下简称"融和智 算"）。 证券代码：300214 证券简称：日科化学 公告编号：2025-059 山东日科化学股份有限公司 合资公司的注册资本为人民币 4,000 万元，其中碳和科技以货币资金出资人 民币 1,960 万元，占注册资本的 49%；融汇公司以货币资金出资人民币 2,040 万 元，占注册资本的 51%。 上述交易统称为"本次投资"。 （二）董事会审议情况 本次投资已于 2025 年 6 月 18 日经公司第六届董事会第五次会议审议通 过，根据《深圳证券交易所创业板股票上市规则》及《公司章程》等规定，本 次投资无需提交股东会审 ...